LANGUAGES
English
اردو
About Us
History
Company Profile
Vision, Mission & Values
Message From CEO
Board of Directors
Contact Us
Partnerships
Product Portfolio
Product List
Pharmaceuticals
Medical Technologies
Exports
Investors
Company Profile
Governance
Corporate Briefing Session
Notice of Corporate Briefing Session 2024
Corporate Briefing Session Presentation 2024
AGM 28-10-2024
Board of Directors
Shareholding Pattern
Name of Auditor & Legal Advisor
Video Message from CEO
Investor Relations
Online Form & Contact Person
Notices of General Meetings, Dividend / Bonus Declarations
Sitemap
Search
Media
Awards
Memberships
News & Updates
Website Last Updated
Election of Directors
Notice of Election of Directors
Detail of Submitted Proxies
Profile of Contesting Candidates
List of Shareholders
Proxy Form
Ballot Paper
Investor Information
PSX Symbol
Financial Ratios
Share Registrar
Free Float 30-09-2024
Code of Conduct
Shareholding Information
List of Non CNIC Shareholders
List of Unclaimed Dividends And Shares
Share Price
Financial Statements
Annual Reports
Interim Accounts
Financial Reports
Compliance Certificate
EHS Policy
Quality Policy
Patients
Disease Info
Drug Safety
Send Query
Physicians
CSR
Press & Media
Videos
Statement on Remdesivir
Statement on Lenacapavir
Financial Ratios
Share Holding Information
Financial Ratios
FY 2024
Earnings Per Share Rs.
9.20
per share
P/E Ratio
27.1
Times
Breakup Value Rs
206.20
per share
Share Value Price
Rs.
294.41
per share as
on
30-06-2024
TOP